Viewing Study NCT05815160

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-01-29 @ 1:57 PM
Study NCT ID: NCT05815160
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-01
First Post: 2023-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
Sponsor: Debiopharm International SA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Platinum-based therapy View
None Small cell lung cancer (SCLC) View
None Recurrent View
None Debio 0123 View
None Carboplatin View
None Etoposide View
None WEE1 inhibitor View
None WEE-1 inhibitor View
None Platinum-based chemotherapy View